Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Journal of Atherosclerosis and Thrombosis|February 4, 2020
Effects of Psychological and Lifestyle Factors on Metabolic Syndrome Following the Fukushima Daiichi Nuclear Power Plant Accident: The Fukushima Health Management SurveyAtsushi Takahashi, Tetsuya Ohira, Kanako Okazaki, et al.
BMJ Open Diabetes Research & Care|September 9, 2021
Suboptimal diabetic control and psychological burden after the triple disaster in Japan: the Fukushima Health Management SurveyHiroyuki Hirai, Kanako Okazaki, Tetsuya Ohira, et al.
Neurobiology of Aging|June 30, 2014
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's diseaseTaku Hatano, Manabu Funayama, Shin-Ichiro Kubo, et al.
Disaster Medicine and Public Health Preparedness|July 31, 2023
Impact of Lifestyle and Psychosocial Factors on the Incidence of Hepatobiliary Enzyme Abnormalities After the Great East Japan Earthquake: Seven-Year Follow-up of the Fukushima Health Management SurveyAtsushi Takahashi, Tetsuya Ohira, Fumikazu Hayashi, et al.
Scientific Reports|March 24, 2017
Decreased 16:0/20:4-phosphatidylinositol level in the post-mortem prefrontal cortex of elderly patients with schizophreniaJunya Matsumoto, Hiroki Nakanishi, Yasuto Kunii, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Evacuation after the Great East Japan Earthquake is an independent factor associated with hyperuricemia: The Fukushima Health Management SurveyKazuya Honda, Kanako Okazaki, Kenichi Tanaka, et al.
Psychiatry Research|December 16, 2018
Pathological alterations of chondroitin sulfate moiety in postmortem hippocampus of patients with schizophreniaTakayuki Yukawa, Yuriko Iwakura, Nobuyuki Takei, et al.
Plos One|October 26, 2023
Relationship between evacuation after the Great East Japan Earthquake and new-onset hyperuricemia: A 7-year prospective longitudinal study of the Fukushima Health Management SurveyKazuya Honda, Kanako Okazaki, Kenichi Tanaka, et al.
Molecular Cytogenetics|July 3, 2015
Assessment of copy number variations in the brain genome of schizophrenia patientsMiwako Sakai, Yuichiro Watanabe, Toshiyuki Someya, et al.
Ebiomedicine|July 1, 2019
Investigation of betaine as a novel psychotherapeutic for schizophreniaTetsuo Ohnishi, Shabeesh Balan, Manabu Toyoshima, et al.
Pageof 22